PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPancrelipase
Pancrelipase
Creon, Pancreaze, Pertzye, Viokace, Zenpep (pancrelipase) is an enzyme pharmaceutical. Pancrelipase was first approved as Cotazym on 1996-12-09.
Download report
Favorite
Top 200 Pharmaceuticals by Retail Sales
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Creon, Pancreaze, Pertzye, Viokace, Zenpep (discontinued: Cotazym)
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Pancrelipase
Tradename
Proper name
Company
Number
Date
Products
CreonpancrelipaseAbbVieN-20725 RX2009-04-30
5 products
PertzyepancrelipaseDigestive CareN-22175 RX2012-05-17
4 products
PancreazepancrelipaseVivusN-22523 RX2010-04-12
6 products
ViokacepancrelipaseViokaceN-22542 RX2012-03-01
2 products
ZenpeppancrelipaseZenpepN-22210 RX2009-08-27
8 products
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
creonBiologic Licensing Application2024-02-28
festal plusunapproved drug other2024-09-03
pancreazeBiologic Licensing Application2025-06-06
pertzyeBiologic Licensing Application2024-03-11
stozymeunapproved drug other2019-11-04
viokaceBiologic Licensing Application2025-08-14
zenpepBiologic Licensing Application2025-11-14
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
83 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Exocrine pancreatic insufficiencyD010188—K86.81351715745
Cystic fibrosisD003550EFO_0000390E84—1106421
Pancreatic neoplasmsD010190EFO_0003860C2544—3514
Chronic pancreatitisD050500EFO_0000342K86.13144214
FibrosisD005355———171312
PancreatitisD010195EFO_0000278K852131310
SteatorrheaD045602——1141—7
Irritable bowel syndromeD043183EFO_0000555K58———112
DiarrheaD003967—R19.7———112
DyspepsiaD004415EFO_0008533K30———112
Show 8 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MalnutritionD044342EFO_0008572E40-E46—11—23
Malabsorption syndromesD008286EFO_0009554K90—11——2
PancreatectomyD010180EFO_0002581———2——2
Abdominal painD015746EFO_0003766R10.9——1—12
SepsisD018805EFO_0001420A41.9—11——1
Child nutrition disordersD015362———11——1
Chronic kidney failureD007676EFO_0003884N18.6——1——1
Renal insufficiencyD051437—N19——1——1
EructationD004884—R14.2——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Short bowel syndromeD012778—K90.82—1———1
Pancreatic ductal carcinomaD021441——11———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369—C802————2
Cerebral palsyD002547—G801————1
HypoglycemiaD007003—E16.21————1
Type 1 diabetes mellitusD003922EFO_0001359E101————1
Renal cell carcinomaD002292EFO_0000376—1————1
CarcinomaD002277—C80.01————1
Hepatocellular carcinomaD006528—C22.01————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Digestive system diseasesD004066EFO_0000405K92.9————33
Pancreatic diseasesD010182—K86.9————33
Gastrointestinal diseasesD005767——————22
Lung neoplasmsD008175—C34.90————11
HemorrhageD006470MP_0001914R58————11
Postoperative complicationsD011183——————11
Pancreatic fistulaD010185——————11
GastroparesisD018589EFO_1000948K31.84————11
FistulaD005402——————11
Acute hemorrhagic pancreatitisD000081032——————11
Show 6 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePancrelipase
INN_
Description
Pancreatic enzymes, also known as pancreases or pancrelipase and pancreatin, are commercial mixtures of amylase, lipase, protease and lactase. They are used to treat malabsorption syndrome due to certain pancreatic problems. These pancreatic problems may be due to cystic fibrosis, surgical removal of the pancreas, long term pancreatitis, pancreatic cancer, or MODY 5, among others. The preparation is taken by mouth.
Classification
Enzyme
Drug classenzymes
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL2108074
ChEBI ID—
PubChem CID—
DrugBankDB00085
UNII IDFQ3DRG0N5K (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Pancreaze – Vivus
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Zenpep – Allergan
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Zenpep – Warner Chilcott
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Creon – Viatris
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Creon – AbbVie
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Pancrelipase
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Pancrelipase
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 10,722 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
19,115 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use